about
Abundance of type I toxin-antitoxin systems in bacteria: searches for new candidates and discovery of novel familiesThe tmRNA ribosome-rescue systemAcquired inducible antimicrobial resistance in Gram-positive bacteriaMolecular basis for erythromycin-dependent ribosome stalling during translation of the ErmBL leader peptideAn exit cavity was crucial to the polymerase activity of the early ribosomeMacrolide antibiotics allosterically predispose the ribosome for translation arrest.A method for selecting cis-acting regulatory sequences that respond to small molecule effectorsThe Berkeleylactones, Antibiotic Macrolides from Fungal Coculture.Critical 23S rRNA interactions for macrolide-dependent ribosome stalling on the ErmCL nascent peptide chain.Relaxed selection drives a noisy noncoding transcriptome in members of the Mycobacterium tuberculosis complex.The arginine attenuator peptide interferes with the ribosome peptidyl transferase center.Probing translation with small-molecule inhibitorsThe key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide.Small proteins can no longer be ignoredSequence requirements for ribosome stalling by the arginine attenuator peptide.Sequence selectivity of macrolide-induced translational attenuationThe general mode of translation inhibition by macrolide antibioticsRecruitment of a species-specific translational arrest module to monitor different cellular processes.Mechanisms of integral membrane protein insertion and foldingAllosteric vs. spontaneous exit-site (E-site) tRNA dissociation early in protein synthesisRecognition of the regulatory nascent chain TnaC by the ribosomeMechanisms of SecM-mediated stalling in the ribosomeNascent chain-monitored remodeling of the Sec machinery for salinity adaptation of marine bacteria.Resistance to ketolide antibiotics by coordinated expression of rRNA methyltransferases in a bacterial producer of natural ketolides.Mechanisms of ribosome stalling by SecM at multiple elongation steps.Arginine changes the conformation of the arginine attenuator peptide relative to the ribosome tunnelThe genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147LNascent peptides that block protein synthesis in bacteria.Regional discrimination and propagation of local rearrangements along the ribosomal exit tunnel.The double life of antibiotics.Regulation of gene expression by macrolide-induced ribosomal frameshifting.Binding of Macrolide Antibiotics Leads to Ribosomal Selection against Specific Substrates Based on Their Charge and Size.The Expression of Antibiotic Resistance Methyltransferase Correlates with mRNA Stability Independently of Ribosome Stalling.Interactions of the TnaC nascent peptide with rRNA in the exit tunnel enable the ribosome to respond to free tryptophan.A structural view on the mechanism of the ribosome-catalyzed peptide bond formation.Divergent stalling sequences sense and control cellular physiology.Regulation of bacterial gene expression by ribosome stalling and rescuing.Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin.Resistance to Macrolide Antibiotics in Public Health Pathogens.Environmental and genetic modulation of the phenotypic expression of antibiotic resistance.
P2860
Q24633108-351FC0B7-A008-4A3F-8ADA-80517BBFC299Q26860816-6FA133CB-244E-4101-8670-44A02B91ABD9Q27027012-4673414D-A0D1-46E5-B10B-9B7E0614C92FQ27682411-E90C3CF9-EEEA-49AE-9186-18A149643B71Q28732449-A5188236-A88B-4764-824E-65405D6B5431Q30584257-EB66FBD7-520E-42FA-9B24-EC33B6507B56Q30986921-293DA6A8-B545-4DDB-A0C7-EB37856A5569Q33787717-8E3CE975-8F46-4F2E-B748-588A1EA8C156Q33878421-58B9A87D-E69C-4410-8ED4-C686C13925C2Q34026241-7C1B27FD-37C4-455C-B262-048981F1F8FBQ34031513-3CBDDCCB-94FE-488A-A811-4BD9416B39D5Q34038634-6577844C-6867-44B7-A865-9DAE7DC0CB47Q34148533-4726219F-B78F-4CC0-BA88-4E5C673785F1Q34200467-A3A04F50-14EE-41A3-9C59-437C5A34E912Q34412752-B3A60F1B-ECAC-482D-B754-CE2F5B5F9E10Q34442039-EBA571B3-B906-4257-8BB8-29C86FDEB246Q34526342-56CAA626-6ABF-4B6B-BDC6-CD3E234CE181Q34794882-37073E2F-670E-476B-AEFB-9648BA7F64E2Q35118815-34E85040-8807-4FFB-B1DA-2EEB81D3400DQ35345094-B9502126-F979-4518-8A90-F59E72543AD8Q35630043-2D44C48D-BF08-45AC-86E8-DFFA8AE2E71CQ36105305-FAA418A7-B899-4266-B854-7B71D35CB322Q36155063-047A4DEF-77DF-461E-9079-E3FA35FA66CFQ36207357-BF76F749-390A-44AD-B853-F653BA643131Q36534007-6AE21180-37F8-41C1-BB67-F061A7592C1CQ36600266-691B963C-F61E-4210-AEF2-C86003D17A2DQ36667049-B77524D9-E9F3-43E8-BD31-1DC9A4AF8ACEQ36673038-958AC136-79D5-4D51-A95A-2DA0310736DFQ37163477-69EE53D6-F057-4E49-A133-47371F7088EBQ37375780-4423258D-9084-428C-A973-DE0AF34464C9Q37418561-FC848E83-B1E3-4EAD-8980-D73A082E310AQ37428512-D135C791-2575-405B-AD0B-26F665139C4BQ37428633-B10A0256-E6F6-4DA6-A14E-E86C01DFF956Q37518622-93660575-D392-4C5D-B00C-31C8D3E6D768Q37549187-9E454AAD-2980-4ACB-B2C9-BF7B72F8147AQ37684316-E3E1121C-698B-4A7A-9397-DD26FC403866Q38649943-48A4A802-E3C9-4B26-92EA-CA980C2B6BCDQ38804355-706CE054-3AAB-49C8-88EA-7A645A0BB2AEQ38928353-7C6B44E2-457E-4F5B-A63B-322F4D5AEB0AQ39195574-3DB84665-B1B6-4F30-A389-2449EB0AB2B3
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Programmed drug-dependent ribosome stalling.
@en
Programmed drug-dependent ribosome stalling.
@nl
type
label
Programmed drug-dependent ribosome stalling.
@en
Programmed drug-dependent ribosome stalling.
@nl
prefLabel
Programmed drug-dependent ribosome stalling.
@en
Programmed drug-dependent ribosome stalling.
@nl
P2093
P2860
P1476
Programmed drug-dependent ribosome stalling.
@en
P2093
Alexander Mankin
Haripriya Ramu
Nora Vazquez-Laslop
P2860
P304
P356
10.1111/J.1365-2958.2008.06576.X
P407
P577
2008-11-30T00:00:00Z